The purpose of the Innovative medical technology overview (IMTO) is to provide manufacturers/distributors of non-medicine technologies the opportunity to submit their clinical and cost effectiveness evidence for independent assessment within NHS Scotland. The aim of an IMTO is to provide objective information that will contribute to the local decision-making of NHS health professionals. IMTOs do not contain recommendations for NHSScotland.
Health technology assessments are becoming a topic with high impact on decision-making in more and more countries across the world. A report from Canada or Australia is likely to be referenced in European evaluations. After the successful introduction of our European HTA Update service, which is used by industry, as well as hospital/national HTA bodies and payers, we are extending this service to a global reach. HTA Update provides a unique solution dedicated to medical devices and diagnostics. Contact us to learn more about how this service can be of value for your organization.
Draft List includes 3 medical aids and 207 implantable medical devices. After review, the List shall be approved by the Decree of Russian Covernment. Devices, included in the List, will be subject for pricing regulation, although pricing framekwork is not yet established.
In the last few days we did some early research about a couple of topics and the possibility to analyze data to answer a market access question. See interesting examples of value of registry information to answer specific research questions about longevity of pacemakers/ICD and improvements in would care.
Our analytical service, HTA Update, detected 33 reports, related to 12 technologies published or initiated by health technology assessment authorities from six European countries in October 2014.
For many medical device companies HTA has been an abstract topic that is being frequently discussed, but that has limited or no impact in the uptake of new products in many countries. HTAs would neither stop funding nor provide additional funding for valuable innovations. This is likely to change rapidly in the next few years. One of the first changes that is likely to come is the German introduction of an early assessment of new technologies.